Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical data indicate RTS,S/AS01E malaria vaccine is safe in infants and children

Nov. 15, 2010

NCX-429 has anti-inflammatory activity in several preclinical models

Nov. 12, 2010

Exenatide is beneficial in patients with nonalcoholic steatohepatitis

Nov. 12, 2010

MenACWY-CRM produces robust immunogenicity in infants

Nov. 12, 2010

DEN1-80E and DEN-80E dengue virus vaccines show promise

Nov. 12, 2010

Fosfomycin/tobramycin improves lung function in patients with CF and lung infections

Nov. 11, 2010

RO-2492 alleviates symptoms of collagen-induced arthritis in mice

Nov. 11, 2010

V-211 vaccine reduces incidence of shingles in adults aged 50-59 years in phase III trial

Nov. 11, 2010

TG-003 may be beneficial in Duchenne's muscular dystrophy

Nov. 11, 2010

Preclinical and clinical data reported on yellow fever vaccine XRX-001

Nov. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...